Cell and Gene Therapy Insights

CELL AND GENE THERAPY INSIGHTS

March 2024

Cell and Gene Therapy Insights Vol 10 Issue 2
View Issue

Vol 10 Issue 2

Spotlight: Non-clinical/translational tools & technologies

View Spotlight

Vectors focus: Scalability 2024

View Focus

Upcoming webinars

Entering the fast lane of assay validation for cell and gene therapies

Entering the fast lane of assay validation for cell and gene therapies

C Bravery, M Bruno, A Kamath et al.
16 April
Today
Register
Increased productivity in the analytical testing of AAV titers with an automated immunoassay platform

Increased productivity in the analytical testing of AAV titers with an automated immunoassay platform

E Feeley, M Gianneli, J Venet
17 April
in 2
Days
Register
Optimizing access to high quality, standardized, and compliant leukopaks for the development and commercialization of allogeneic therapies

Optimizing access to high quality, standardized, and compliant leukopaks for the development and commercialization of allogeneic therapies

Makensie Becker
18 April
in 3
Days
Register
Overcoming the limits of lentivirus: de-risk cell therapy development with non-viral genome engineering

Overcoming the limits of lentivirus: de-risk cell therapy development with non-viral genome engineering

Miles Smith
23 April
in 8
Days
Register
Accelerate the scale-up to clinical phase: optimizing stem cell culture performance and viral vector titers

Accelerate the scale-up to clinical phase: optimizing stem cell culture performance and viral vector titers

Sara Bursomanno
24 April
in 9
Days
Register
Integrated plasmid engineering and manufacturing process: a unified approach from lab to clinic

Integrated plasmid engineering and manufacturing process: a unified approach from lab to clinic

Pauline Vieugué, PhD, Philippe Ledent, PhD
24 April
in 9
Days
Register
View all webinars

Latest Articles

Delivering on a vision of a digitally enabled future for viral vector manufacturing

Delivering on a vision of a digitally enabled future for viral vector manufacturing

Sönke Brunswieck, Tania Chilima
12 April
Interview
Best practices and considerations for outsourcing with CDMOs

Best practices and considerations for outsourcing with CDMOs

Joseph W Graskemper
11 April
Viewpoint
Harnessing producer cell lines and process intensification to address the AAV process productivity conundrum

Harnessing producer cell lines and process intensification to address the AAV process productivity conundrum

Ying Cai
10 April
Interview
Regulatory strategies for developing and manufacturing RNA-LNPs

Regulatory strategies for developing and manufacturing RNA-LNPs

Alexander Aust
5 April
Viewpoint
Advancing gene therapy development with a multi-serotype AAV affinity resin

Advancing gene therapy development with a multi-serotype AAV affinity resin

Nicolas Laroudie, Quentin Bazot
4 April
Innovator Insight
5 best practices for lentiviral purification and downstream processing success

5 best practices for lentiviral purification and downstream processing success

4 April
Poster
5 dos and don'ts for regulatory compliance in AAV manufacturing

5 dos and don'ts for regulatory compliance in AAV manufacturing

4 April
Poster
Gene therapy is having a monumental year: how can the industry keep up with supply?

Gene therapy is having a monumental year: how can the industry keep up with supply?

Suman Subramanian
4 April
Interview
Combining best practices and analytical reference materials to tackle challenges in AAV manufacturing

Combining best practices and analytical reference materials to tackle challenges in AAV manufacturing

Mark Verdecia
3 April
Commentary

Channel content

The power of plants as vaccine production platforms

The power of plants as vaccine production platforms

Kathleen Hefferon
12 April
Maintaining ‘warm base’ capacity for pandemic preparedness

Maintaining ‘warm base’ capacity for pandemic preparedness

Kilian Mullett
12 April
How can investing in technology transfers help build a sustainable manufacturing ecosystem? An example from cholera

How can investing in technology transfers help build a sustainable manufacturing ecosystem? An example from cholera

Jeanette Hayes, Charlotte Weller
12 April
View channel
Best practices and considerations for outsourcing with CDMOs

Best practices and considerations for outsourcing with CDMOs

Joseph W Graskemper
11 April
Advancing capsid engineering: improving tropism and delivery efficiency of AAV

Advancing capsid engineering: improving tropism and delivery efficiency of AAV

Li Ou
26 March
Transient and suspension: scalable yet flexible single-use process for multiple AAV serotypes

Transient and suspension: scalable yet flexible single-use process for multiple AAV serotypes

Johanna Viiliäinen
19 March
View channel
Impact of glycosylation of vaccine antigens on quality and performance

Impact of glycosylation of vaccine antigens on quality and performance

John F Cipollo, Diane McCarthy
12 April
Regulatory strategies for developing and manufacturing RNA-LNPs

Regulatory strategies for developing and manufacturing RNA-LNPs

Alexander Aust
5 April
Combining best practices and analytical reference materials to tackle challenges in AAV manufacturing

Combining best practices and analytical reference materials to tackle challenges in AAV manufacturing

Mark Verdecia
3 April
View channel
Best practices and considerations for outsourcing with CDMOs

Best practices and considerations for outsourcing with CDMOs

Joseph W Graskemper
11 April
Regulatory strategies for developing and manufacturing RNA-LNPs

Regulatory strategies for developing and manufacturing RNA-LNPs

Alexander Aust
5 April
Insights into advanced therapies in the context of evolving funding and M&A environments

Insights into advanced therapies in the context of evolving funding and M&A environments

Lee Brown
26 March
View channel
Regulatory strategies for developing and manufacturing RNA-LNPs

Regulatory strategies for developing and manufacturing RNA-LNPs

Alexander Aust
5 April
Gene therapy is having a monumental year: how can the industry keep up with supply?

Gene therapy is having a monumental year: how can the industry keep up with supply?

Suman Subramanian
4 April
Combining best practices and analytical reference materials to tackle challenges in AAV manufacturing

Combining best practices and analytical reference materials to tackle challenges in AAV manufacturing

Mark Verdecia
3 April
View channel
Gene therapy is having a monumental year: how can the industry keep up with supply?

Gene therapy is having a monumental year: how can the industry keep up with supply?

Suman Subramanian
4 April
AI and iPSCs: current applications for characterization and quality control

AI and iPSCs: current applications for characterization and quality control

Jonathan Dack
26 March
Achieving scalability: strategic insights into avoiding the pitfalls of the cell and gene therapy supply chain

Achieving scalability: strategic insights into avoiding the pitfalls of the cell and gene therapy supply chain

Donna Rill
19 March
View channel
Looking to a future of multiplex cell engineering

Looking to a future of multiplex cell engineering

Marco Alessandrini
11 January
Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids

Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids

Zhenghong Gao
5 January
Biological & operational considerations for iPSC-derived cell production

Biological & operational considerations for iPSC-derived cell production

Austin Mogen, Antonio Fernandez-Perez, Jiwu Wang et al.
20 December 2023
View channel